Department of Gynecology and Obstetrics, School of Medicine, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
Department of Health Informatics, Institute of Public Health, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia.
BMC Pregnancy Childbirth. 2021 Oct 29;21(1):734. doi: 10.1186/s12884-021-04199-1.
The incidence of eclampsia and its adverse maternal outcomes are very high in developing countries, particularly in Subsaharan African Countries. Identifying predictors for adverse maternal outcomes of eclampsia has paramount importance for helping health care providers to optimize their management outcomes. Therefore, this study aimed to assess the incidence of adverse maternal outcomes of eclampsia and its determinant factors.
A retrospective follow-up study design was applied. The data were extracted from patient charts using a structured, pre-tested, questionnaire. Descriptive analyses (frequencies, means, and standard deviation) were calculated, and bi-variable and multivariable logistic regression models were used to testing the association between independent variables and an outcome variable. After the data were coded and entered into Epi-Info Version 7.2 Software, the data were analyzed using STATA Version 14 Statistical Software.
The magnitude of eclampsia was 5.36 per 1000 pregnancies (95% CI: 4.72, 6.10). The incidence of adverse maternal outcomes in eclamptic mothers was 53.7% (95% CI: 47.02, 60.24%). After adjusting for covariates maternal age 30-34, AOR 5.4 [95% CI = 1.02, 28.6]; age above 34, AOR 10.5 [95% CI = 1.3, 88.6]; gravidity 2-4, AOR 0.3 [95% CI = 0.1, 0.9]; 10 or more convulsions, AOR 4.6 [95% CI = 1.4, 14.9]; mild pyrexia, AOR 20.4 [95% CI = 3.7, 112.7]; moderate pyrexia, AOR 14.6 [95% CI = 1.7125.1]; platelet count below 50,000 cells/mm, AOR 34.9 [95% CI = 3.6, 336.2]; platelet count between 50,000 and 99,000 cells/mm, AOR 24.5 [95%CI = 5.4111.6]; and stillbirth of the current pregnancy, AOR 23.2 [95%CI = 2.1257.5] were strong predictors of adverse maternal outcomes in eclamptic mothers.
The incidence of adverse maternal outcomes of eclampsia was found to be high compared to similar studies discussed in this study. This study recommends early identification of patients with the risk factors (having many convulsions, high body temperature, low platelet count, patient age above 30 years, and 2-4 pregnancies), strengthening the referral system, and advocation of research on the area of adverse maternal outcomes and thereby encourage evidence-based medicine.
子痫的发病率及其对产妇的不良结局在发展中国家,尤其是撒哈拉以南非洲国家非常高。确定子痫不良产妇结局的预测因素对于帮助医疗保健提供者优化管理结果至关重要。因此,本研究旨在评估子痫不良产妇结局的发生率及其决定因素。
采用回顾性随访研究设计。使用结构化、预测试、问卷从病历中提取数据。计算描述性分析(频率、平均值和标准差),并使用双变量和多变量逻辑回归模型测试独立变量与结果变量之间的关联。数据编码并输入 Epi-Info 版本 7.2 软件后,使用 STATA 版本 14 统计软件进行数据分析。
子痫的发生率为每 1000 例妊娠 5.36 例(95%CI:4.72,6.10)。子痫产妇不良产妇结局的发生率为 53.7%(95%CI:47.02,60.24%)。调整协变量后,产妇年龄 30-34 岁,OR5.4[95%CI=1.02,28.6];年龄 34 岁以上,OR10.5[95%CI=1.3,88.6];孕次 2-4 次,OR0.3[95%CI=0.1,0.9];10 次以上抽搐,OR4.6[95%CI=1.4,14.9];轻度发热,OR20.4[95%CI=3.7,112.7];中度发热,OR14.6[95%CI=1.7125.1];血小板计数<50,000 细胞/mm,OR34.9[95%CI=3.6,336.2];血小板计数 50,000-99,000 细胞/mm,OR24.5[95%CI=5.4111.6];当前妊娠死产,OR23.2[95%CI=2.1257.5]是子痫产妇不良产妇结局的强预测因素。
与本研究中讨论的类似研究相比,发现子痫不良产妇结局的发生率较高。本研究建议早期识别具有危险因素(抽搐次数多、体温高、血小板计数低、产妇年龄 30 岁以上、孕次 2-4 次)的患者,加强转诊系统,并倡导对不良产妇结局领域进行研究,从而鼓励循证医学。